Jason Grebely

26.9k total citations · 10 hit papers
358 papers, 14.8k citations indexed

About

Jason Grebely is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Jason Grebely has authored 358 papers receiving a total of 14.8k indexed citations (citations by other indexed papers that have themselves been cited), including 312 papers in Hepatology, 307 papers in Epidemiology and 78 papers in Infectious Diseases. Recurrent topics in Jason Grebely's work include Hepatitis C virus research (312 papers), Hepatitis B Virus Studies (182 papers) and HIV, Drug Use, Sexual Risk (138 papers). Jason Grebely is often cited by papers focused on Hepatitis C virus research (312 papers), Hepatitis B Virus Studies (182 papers) and HIV, Drug Use, Sexual Risk (138 papers). Jason Grebely collaborates with scholars based in Australia, Canada and United Kingdom. Jason Grebely's co-authors include Gregory J. Dore, Behzad Hajarizadeh, Matthew Hickman, Louisa Degenhardt, Sarah Larney, Peter Vickerman, Evan B. Cunningham, Margaret Hellard, Andrew R. Lloyd and Amy Peacock and has published in prestigious journals such as The Lancet, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Jason Grebely

341 papers receiving 14.5k citations

Hit Papers

Global prevalence of inje... 2013 2026 2017 2021 2017 2013 2018 2019 2013 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
    2017 996 citations Louisa Degenhardt, Amy Peacock et al. profile →
  2. Epidemiology and natural history of HCV infection
    2013 755 citations Behzad Hajarizadeh, Jason Grebely et al. profile →
  3. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report
    2018 697 citations Amy Peacock, Sarah Larney et al. Addiction profile →
  4. Global patterns of opioid use and dependence: harms to populations, interventions, and future action
    2019 496 citations Louisa Degenhardt, Jason Grebely et al. profile →
  5. Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals
    2013 368 citations Natasha K. Martin, Peter Vickerman et al. profile →
  6. Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
    2017 344 citations Behzad Hajarizadeh, Jason Grebely et al. Journal of Hepatology profile →
  7. Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States
    2015 326 citations Jason Grebely, Gregory J. Dore et al. profile →
  8. Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence
    2021 323 citations Thomas Santo, Brodie Clark et al. profile →
  9. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review
    2017 293 citations Sarah Larney, Amy Peacock et al. profile →
  10. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review
    2023 109 citations Louisa Degenhardt, Paige Webb et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jason Grebely 12.2k 10.7k 3.1k 2.0k 767 358 14.8k
Holly Hagan 8.2k 0.7× 4.4k 0.4× 3.8k 1.2× 1.9k 1.0× 1.5k 2.0× 190 9.7k
Gregory J. Dore 18.3k 1.5× 18.1k 1.7× 5.0k 1.6× 925 0.5× 614 0.8× 508 23.4k
Gregory D. Kirk 6.1k 0.5× 3.7k 0.3× 2.7k 0.9× 861 0.4× 608 0.8× 271 10.8k
Judith A. Hahn 5.3k 0.4× 2.0k 0.2× 3.4k 1.1× 872 0.4× 1.6k 2.0× 196 7.3k
Julie Bruneau 4.7k 0.4× 2.0k 0.2× 1.9k 0.6× 2.2k 1.1× 580 0.8× 211 8.1k
Sarah Larney 4.9k 0.4× 1.6k 0.1× 1.3k 0.4× 3.0k 1.5× 783 1.0× 160 7.0k
Vivian Hope 3.9k 0.3× 1.8k 0.2× 1.6k 0.5× 1.3k 0.7× 424 0.6× 147 5.0k
Karen L. Lindsay 9.0k 0.7× 9.5k 0.9× 793 0.3× 544 0.3× 219 0.3× 150 12.9k
Lucas Wiessing 4.5k 0.4× 1.3k 0.1× 1.9k 0.6× 2.2k 1.1× 543 0.7× 82 5.6k
Bradley Mathers 4.2k 0.3× 1.2k 0.1× 2.2k 0.7× 1.8k 0.9× 514 0.7× 38 5.1k

Countries citing papers authored by Jason Grebely

Since Specialization
Citations

This map shows the geographic impact of Jason Grebely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Grebely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Grebely more than expected).

Fields of papers citing papers by Jason Grebely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Grebely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Grebely. The network helps show where Jason Grebely may publish in the future.

Co-authorship network of co-authors of Jason Grebely

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Grebely. A scholar is included among the top collaborators of Jason Grebely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Grebely. Jason Grebely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conway, Anna, Alison D. Marshall, Jason Grebely, Guillaume Fontaine, & Carla Treloar. (2025). Professional identities and new technologies of hepatitis C point-of-care testing. Social Science & Medicine. 378. 118140–118140. 1 indexed citations
2.
Price, Olivia, Paige Webb, Jason Grebely, et al.. (2025). Sexually transmitted infection prevalence and testing coverage among people who inject drugs: A systematic review. Drug and Alcohol Dependence. 273. 112732–112732.
3.
Marshall, Alison D., et al.. (2024). Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study. International Journal of Drug Policy. 129. 104477–104477.
4.
Ryan, Hannah, Gregory J. Dore, Jason Grebely, et al.. (2024). Hepatitis C treatment outcome among people in prison: The SToP‐C study. Liver International. 44(11). 2996–3007. 2 indexed citations
5.
Price, Olivia, Jason Grebely, Behzad Hajarizadeh, et al.. (2024). Vaccination coverage among people who inject drugs: A systematic review. International Journal of Drug Policy. 127. 104382–104382. 4 indexed citations
6.
Conway, Anna, Alison D. Marshall, Sione Crawford, et al.. (2023). Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study. Implementation Science. 18(1). 22–22. 1 indexed citations
7.
Conway, Anna, Cherie Power, Anna McNulty, et al.. (2023). Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study. Open Forum Infectious Diseases. 10(11). ofad517–ofad517. 5 indexed citations
8.
Martinello, Marianne, Sanjay Bhagani, David Shaw, et al.. (2023). Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study. JHEP Reports. 5(10). 100867–100867. 4 indexed citations
9.
Bharat, Chrianna, Paige Webb, Rebecca McKetin, et al.. (2023). Agreement between self‐reported illicit drug use and biological samples: a systematic review and meta‐analysis. Addiction. 118(9). 1624–1648. 62 indexed citations
10.
Cunningham, Evan B., Alice Wheeler, Behzad Hajarizadeh, et al.. (2022). Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis. International Journal of Drug Policy. 111. 103917–103917. 31 indexed citations
11.
Grebely, Jason, Lucy Thi Tran, Behzad Hajarizadeh, et al.. (2020). Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis. Addiction. 116(7). 1664–1676. 9 indexed citations
12.
Artenie, Andreea Adelina, Geng Zang, Didier Jutras‐Aswad, et al.. (2019). Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada. Addiction. 114(8). 1495–1503. 6 indexed citations
13.
Catlett, Beth, F. Lamoury, Sahar Bajis, et al.. (2019). Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study. Journal of Viral Hepatitis. 26(12). 1423–1430. 13 indexed citations
14.
Hajarizadeh, Behzad, Evan B. Cunningham, Heather Valerio, et al.. (2019). Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis. Journal of Hepatology. 72(4). 643–657. 114 indexed citations
15.
Larance, Briony, Louisa Degenhardt, Jason Grebely, et al.. (2019). Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia. Addiction. 115(7). 1295–1305. 57 indexed citations
16.
Bruneau, Julie, Suzanne K. Fish, Niklas Luhmann, et al.. (2019). Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs. International Journal of Drug Policy. 66. 87–93. 23 indexed citations
17.
Lamoury, F., Behzad Hajarizadeh, Camelia Quek, et al.. (2018). Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot Samples. Journal of Molecular Diagnostics. 20(5). 621–627. 19 indexed citations
18.
Hellard, Margaret, Carla Treloar, Julie Bruneau, et al.. (2018). Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework. Liver International. 39(1). 20–30. 83 indexed citations
19.
Alavi, Maryam, Naveed Z. Janjua, Mei Chong, et al.. (2017). Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study. Journal of Viral Hepatitis. 25(5). 473–481. 15 indexed citations
20.
Jacka, Brendan, Bethany C. Bray, Tanya Applegate, et al.. (2017). Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach. Journal of Viral Hepatitis. 25(1). 28–36. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Holly Hagan Breakdown of academic impact, for papers by Gregory J. Dore Breakdown of academic impact, for papers by Gregory D. Kirk Breakdown of academic impact, for papers by Judith A. Hahn Breakdown of academic impact, for papers by Julie Bruneau Breakdown of academic impact, for papers by Sarah Larney Breakdown of academic impact, for papers by Vivian Hope Breakdown of academic impact, for papers by Karen L. Lindsay Breakdown of academic impact, for papers by Lucas Wiessing Breakdown of academic impact, for papers by Bradley Mathers
Rankless by CCL
2026